Versameb

Basel, Switzerland

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

$10.0M raised

Jun 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Versameb raised?

Versameb has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in June 2023.

Who are Versameb's investors?

Versameb's investors include Bernina BioInvest.

Where is Versameb headquartered?

Versameb is headquartered in Basel, Switzerland.

What does Versameb do?

Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.

What stage is Versameb at?

Versameb is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 14, 2023.

MLA

"Versameb — Funding & Investors." VCBacked, June 14, 2023, https://www.vcbacked.co/company/versameb. Accessed July 2, 2026.

APA

VCBacked. (2023). Versameb — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/versameb

Wikipedia (cite web)

{{cite web |title=Versameb — Funding & Investors |url=https://www.vcbacked.co/company/versameb |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 14, 2023.